1
|
Kamble P, Malavekar D, Tiwari AP. Natural Biowaste Derived Fluorescent Carbon Quantum Dots: Synthesis, Characterization and Biocompatibility Study. J Fluoresc 2024; 34:191-201. [PMID: 37166612 DOI: 10.1007/s10895-023-03244-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Accepted: 04/14/2023] [Indexed: 05/12/2023]
Abstract
In this present study, a straightforward and affordable method for the environmentally safe synthesis of carbon quantum dots (CQDs) by employing human hair as the carbon source without any need of chemicals was synthesized. CQDs obtained from human hair was further functionalized with Poly-L-Lysine to form PLLCQDs. The synthesized PLLCQDs was demonstrated numerous advantageous characteristics like strong fluorescence intensity, superior photostability, and outstanding water solubility. Various physicochemical characterization was employed to confirm successful formation of PLLCQDs including UV-vis Spectroscopy, Fluorescence Spectroscopy, Fourier Transform Infrared (FTIR) Spectroscopy, Atomic Force Microscopy (AFM) and Transmission Electron Microscopy (TEM). The size of synthesized PLLCQDs is 3 nm. The resultant PLLCQDs exhibited strong blue emission with a quantum yield of 28%. Under UV light, the synthesized PLLCQDs emit blue (at 365nm) fluorescence. The optimization of synthesis parameters including synthesis method, effect of reaction temperature, effect of reaction time and effect of reaction concentration have a significant impact on the quality and quantity of synthesized PLLCQDs, as well as their properties and applications. The effect of pH and UV radiation on synthesized PLLCQDs exhibited excellent photo and chemical stability. The cytotoxicity of bulk system (Hair precursor) and PLLCQDs was evaluated using fibroblast cell line (L929). The cell viabilities of 99.47% was obtained from L929 cells using MTT assay and it can applicably function as agents for cell labelling as a good bioimaging probe.
Collapse
Affiliation(s)
- Pranoti Kamble
- Department of Medical Biotechnology and Stem cell and Regenerative Medicine, Centre for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be university), Kolhapur, Maharashtra, India
| | - Dhanaji Malavekar
- Department of Materials Science and Engineering, Optoelectronic Convergence Research Centre, Chonnam National University, Gwangju, 61186, South Korea
| | - Arpita Pandey Tiwari
- Department of Medical Biotechnology and Stem cell and Regenerative Medicine, Centre for Interdisciplinary Research, D. Y. Patil Education Society (Deemed to be university), Kolhapur, Maharashtra, India.
| |
Collapse
|
2
|
Kaurav H, Verma D, Bansal A, Kapoor DN, Sheth S. Progress in drug delivery and diagnostic applications of carbon dots: a systematic review. Front Chem 2023; 11:1227843. [PMID: 37521012 PMCID: PMC10375716 DOI: 10.3389/fchem.2023.1227843] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 07/05/2023] [Indexed: 08/01/2023] Open
Abstract
Carbon dots (CDs), which have particle size of less than 10 nm, are carbon-based nanomaterials that are used in a wide range of applications in the area of novel drug delivery in cancer, ocular diseases, infectious diseases, and brain disorders. CDs are biocompatible, eco-friendly, easy to synthesize, and less toxic with excellent chemical inertness, which makes them very good nanocarrier system to deliver multi-functional drugs effectively. A huge number of researchers worldwide are working on CDs-based drug delivery systems to evaluate their versatility and efficacy in the field of pharmaceuticals. As a result, there is a tremendous increase in our understanding of the physicochemical properties, diagnostic and drug delivery aspects of CDs, which consequently has led us to design and develop CDs-based theranostic system for the treatment of multiple disorders. In this review, we aim to summarize the advances in application of CDs as nanocarrier including gene delivery, vaccine delivery and antiviral delivery, that has been carried out in the last 5 years.
Collapse
Affiliation(s)
- Hemlata Kaurav
- School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh, India
| | - Dhriti Verma
- School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh, India
| | - Amit Bansal
- Formulation Research and Development, Perrigo Company Plc, Allegan, MI, United States
| | - Deepak N. Kapoor
- School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh, India
| | - Sandeep Sheth
- Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL, United States
| |
Collapse
|
3
|
Adhel E, Ha Duong NT, Vu TH, Taverna D, Ammar S, Serradji N. Interaction between carbon dots from folic acid and their cellular receptor: a qualitative physicochemical approach. Phys Chem Chem Phys 2023; 25:14324-14333. [PMID: 37183591 DOI: 10.1039/d3cp01277h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
According to the World Health Organization, the number of cancers (all cancers, both sexes, all ages and worldwide) in 2020 reached a total of 19 292 789 new cases leading to 9 958 133 deaths during the same period. Many cancers could be cured if detected early. Preventing cancer and detecting it early are two essential strategies for controlling this pathology. For this purpose, several strategies have been described for imaging cancer cells. One of them is based on the use of carbon nanoparticles called carbon dots, tools of physical chemistry. The literature describes that cancer cells can be imaged using carbon dots obtained from folic acid and that the in cellulo observed photoluminescence probably results from the interaction of these nanoparticles with the folic acid-receptor, a cell surface protein overexpressed in many malignant cells. However, this interaction has never been directly demonstrated yet. We investigated it, for the first time, using (i) freshly synthesized and fully characterized carbon dots, (ii) folate binding protein, a folic acid-receptor model protein and (iii) fluorescence spectroscopy and isothermal titration calorimetry, two powerful methods for detecting molecular interactions. Our results even highlight a selective interaction between these carbon made nano-objects and their biological target.
Collapse
Affiliation(s)
- Erika Adhel
- Université Paris Cité, CNRS, ITODYS, F-75013 Paris, France.
| | | | - Thi Huyen Vu
- University of Engineering and Technology, Vietnam National University, Hanoi (VNUH), Vietnam
| | - Dario Taverna
- Sorbonne Université, CNRS, IMPMC, F-75005 Paris, France
| | - Souad Ammar
- Université Paris Cité, CNRS, ITODYS, F-75013 Paris, France.
| | - Nawal Serradji
- Université Paris Cité, CNRS, ITODYS, F-75013 Paris, France.
| |
Collapse
|
4
|
Green synthesis of multifunctional carbon dots from Crataegi Fructus for pH sensing, cell imaging and hemostatic effects. J Photochem Photobiol A Chem 2022. [DOI: 10.1016/j.jphotochem.2022.114531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
5
|
Liu Q, Song P, Zhang W, Wang Z, Yang K, Luo J, Zhu L, Gui L, Tao Y, Ge F. Acid-Sensitive Nanoparticles Based on Molybdenum Disulfide for Photothermal-Chemo Therapy. ACS Biomater Sci Eng 2022; 8:1706-1716. [PMID: 35291764 DOI: 10.1021/acsbiomaterials.1c01390] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The combination of multiple treatments has recently been investigated for tumor treatment. In this study, molybdenum disulfide (MoS2) with excellent photothermal conversion performance was used as the core, and manganese dioxide (MnO2), which responds to the tumor microenvironment, was loaded on its surface by liquid deposition to form a mesoporous core-shell structure. Then, the chemotherapeutic drug Adriamycin (DOX) was loaded into the hole. To further enhance its water solubility and stability, the surface of MnO2 was modified with mPEG-NH2 to prepare the combined antitumor nanocomposite MoS2@DOX/MnO2-PEG (MDMP). The results showed that MDMP had a diameter of about 236 nm, its photothermal conversion efficiency was 33.7%, and the loading and release rates of DOX were 13 and 65%, respectively. During in vivo and in vitro studies, MDMP showed excellent antitumor activity. Under the combined treatment, the tumor cell viability rate was only 11.8%. This nanocomposite exhibits considerable potential for chemo-photothermal combined antitumor therapy.
Collapse
Affiliation(s)
- Qin Liu
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| | - Ping Song
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| | - Weiwei Zhang
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| | - Zhenyu Wang
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| | - Kai Yang
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, Jiangsu, China
| | - Jianquan Luo
- Institute of Process Engineering, University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
| | - Longbao Zhu
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| | - Lin Gui
- Department of Microbiology and Immunology, Wannan Medical College, Wuhu, Anhui 241002, Peoples Republic of China
| | - Yugui Tao
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| | - Fei Ge
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui 241000, People's Republic of China
| |
Collapse
|
6
|
Chen L, Lin Y, Zhang Z, Yang R, Bai X, Liu Z, Luo Z, Zhou M, Zhong Z. A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer. J Nanobiotechnology 2021; 19:329. [PMID: 34666761 PMCID: PMC8524854 DOI: 10.1186/s12951-021-01064-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Accepted: 09/28/2021] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND There is an obvious correlation between ulcerative colitis and colorectal cancer, and the risk of colorectal cancer in patients with ulcerative colitis is increasing. Therefore, the combination therapy of anti-inflammatory and anti-tumor drugs may show promising to inhibit colon cancer. 5-aminosalicylic acid (5-ASA) with anti-inflammatory function is effective for maintaining remission in patients with ulcerative colitis and may also reduce colorectal cancer risk. Histone deacetylase (HDAC) plays an essential role in the progression of colon cancer. Butyric acid (BA) is a kind of HDAC inhibitor and thus shows tumor suppression to colon cancer. However, the volatile and corrosive nature of BA presents challenges in practical application. In addition, its clinical application is limited due to its non-targeting ability and low bioavailability. We aimed to synthesize a novel dual-prodrug of 5-ASA and BA, referred as BBA, to synergistically inhibit colon cancer. Further, based on the fact that folate receptor (FR) is over-expressed in most solid tumors and it has been identified to be a cancer stem cell surface marker in colon cancer, we took folate as the targeting ligand and used carboxymethyl-β-cyclodextrin (CM-β-CD) to carry BBA and thus prepared a novel inclusion complex of BBA/FA-PEG-CM-β-CD. RESULTS It was found that BBA/FA-PEG-CM-β-CD showed significant inhibition in cell proliferation against colon cancer cells SW620. It showed a pro-longed in vivo circulation and mainly accumulated in tumor tissue. More importantly, BBA/FA-PEG-CM-β-CD gave great tumor suppression effect against nude mice bearing SW620 xenografts. CONCLUSIONS Therefore, BBA/FA-PEG-CM-β-CD may have clinical potential in colon cancer therapy.
Collapse
Affiliation(s)
- Lin Chen
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China.,Nanchong Key Laboratory of Individualized Drug Therapy, Department of Pharmacy, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, 637000, Sichuan, China
| | - Yan Lin
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China
| | - Zijun Zhang
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China
| | - Ruisheng Yang
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China
| | - Xiaosheng Bai
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China
| | - Zhongbing Liu
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China
| | - Zhongling Luo
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China
| | - Meiling Zhou
- Department of Pharmacy, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
| | - Zhirong Zhong
- Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China.
| |
Collapse
|